|
 |
The following assays are now cleared by the FDA: Thyroid Stimulating Hormone (TSH), free Thyroxine (freeT4), Human Chorionic Gonadotropin (hCG), Total Prostate Specific Antigen (tPSA) and Testosterone. Free PSA is available outside the United States. The success of the FastPack® System in the Urology field, coupled with the addition of thyroid function assays, has opened the door to market the system to the following additional medical specialties: Family Practice, Internal Medicine, Urgent Care, OB/GYN and Endocrinology.
Corporate Officers
Paul A. Rosinack
President & CEO, Director
Michael S. Poirier
Senior Vice President, Chief Scientific & Technical Officer
Christopher L. Lotz
Vice President, Chief Financial Officer
Robert D. Buchanan
Vice President, Sales and Marketing
Shishir K. Sinha
Vice President, Operations
Board of Directors
Paul A. Rosinack
President & CEO, Qualigen, Inc.
Paulita M. LaPlante
President & CEO, väsamed, Inc.
Partner, The Center for Urological Treatment, PLLC